Susquehanna International Group, LLP Rubius Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.46 - $1.29 $23,393 - $65,602
50,855 Added 110.24%
96,985 $42,000
Q2 2022

Aug 15, 2022
SELL
$0.79 - $5.98 $20,288 - $153,578
-25,682 Reduced 35.76%
46,130 $39,000
Q1 2022

May 16, 2022
SELL
$4.25 - $10.4 $72,534 - $177,496
-17,067 Reduced 19.2%
71,812 $396,000
Q4 2021

Feb 14, 2022
BUY
$9.68 - $17.74 $430,276 - $788,542
44,450 Added 100.05%
88,879 $860,000
Q3 2021

Nov 15, 2021
BUY
$17.6 - $25.91 $211,956 - $312,034
12,043 Added 37.19%
44,429 $794,000
Q2 2021

Aug 11, 2021
BUY
$22.26 - $28.43 $178,903 - $228,491
8,037 Added 33.01%
32,386 $791,000
Q4 2020

Feb 16, 2021
BUY
$4.23 - $8.73 $102,996 - $212,566
24,349 New
24,349 $185,000
Q3 2020

Nov 16, 2020
SELL
$4.65 - $6.25 $65,695 - $88,300
-14,128 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$4.01 - $6.88 $17,836 - $30,602
-4,448 Reduced 23.94%
14,128 $84,000
Q1 2020

May 15, 2020
BUY
$3.74 - $9.84 $69,474 - $182,787
18,576 New
18,576 $83,000
Q4 2019

Feb 14, 2020
SELL
$7.23 - $14.12 $120,422 - $235,182
-16,656 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$7.85 - $15.75 $14,962 - $30,019
1,906 Added 12.92%
16,656 $131,000
Q2 2019

Aug 16, 2019
BUY
$13.5 - $19.94 $199,125 - $294,115
14,750 New
14,750 $232,000

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email